JPS5718612A - Biologically active mixture - Google Patents

Biologically active mixture

Info

Publication number
JPS5718612A
JPS5718612A JP7290681A JP7290681A JPS5718612A JP S5718612 A JPS5718612 A JP S5718612A JP 7290681 A JP7290681 A JP 7290681A JP 7290681 A JP7290681 A JP 7290681A JP S5718612 A JPS5718612 A JP S5718612A
Authority
JP
Japan
Prior art keywords
biologically active
active mixture
mixture
biologically
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7290681A
Other languages
English (en)
Inventor
Uiruson Jiefurii
Buraian Rii Toomasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of JPS5718612A publication Critical patent/JPS5718612A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP7290681A 1980-05-17 1981-05-16 Biologically active mixture Pending JPS5718612A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8016381 1980-05-17

Publications (1)

Publication Number Publication Date
JPS5718612A true JPS5718612A (en) 1982-01-30

Family

ID=10513492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7290681A Pending JPS5718612A (en) 1980-05-17 1981-05-16 Biologically active mixture

Country Status (4)

Country Link
EP (1) EP0040489A1 (ja)
JP (1) JPS5718612A (ja)
AU (1) AU528276B2 (ja)
DK (1) DK216281A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03200728A (ja) * 1989-02-23 1991-09-02 Glaxo Canada Inc 医薬組成物
JPH0718693U (ja) * 1993-12-29 1995-04-04 信義 島 トイレットペーパ保持具を使用した通報装置

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
HU209245B (en) * 1991-12-20 1994-04-28 Richter Gedeon Vegyeszet Process for producing new cimetidine derivatives, as well as new gastric acid secretion inhibiting and gastrocytoprotective pharmaceuitcal compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1917123A1 (de) * 1969-04-02 1970-10-15 Fisons Pharmaceuticals Ltd Neue Chromon-2-carbonsaeuren
GB1488707A (en) * 1974-07-10 1977-10-12 Fisons Ltd 5-(2-hydroxy-propoxy)-4-oxo-8-propyl-4h-1-benzopyran-2-carboxylic acid and derivatives thereof
GB1582362A (en) * 1977-03-17 1981-01-07 Fisons Ltd Cromoglycic acid salts and compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03200728A (ja) * 1989-02-23 1991-09-02 Glaxo Canada Inc 医薬組成物
JPH0718693U (ja) * 1993-12-29 1995-04-04 信義 島 トイレットペーパ保持具を使用した通報装置

Also Published As

Publication number Publication date
AU7061581A (en) 1982-01-14
DK216281A (da) 1981-11-16
AU528276B2 (en) 1983-04-21
EP0040489A1 (en) 1981-11-25

Similar Documents

Publication Publication Date Title
GB2083827B (en) Biologically active composites
GB2080281B (en) Biologically active glass
IL61037A0 (en) Biologically active peptides
ZA832431B (en) Active compounds
PL245456A1 (en) Insecticide
ZA813931B (en) Active compounds
AU529935B2 (en) Biologically active mixtures
GB8332218D0 (en) Stabilized insecticidal composition
DE3367719D1 (en) Biocidally active mixture
JPS5718612A (en) Biologically active mixture
GB2086396B (en) Biologically active peptides
BG40311A3 (en) Insecticide composition
ZA812631B (en) Pharmaceologically active compounds
GB8427027D0 (en) Biologically active penta- & heptapepitdes
JPS5611795A (en) Biologically active substance
PL241455A1 (en) Pesticide mixture
JPS5668651A (en) Novel biologically active peptide
GR80447B (en) Biologically active sulphur compounds
GB8309547D0 (en) Biologically active peptides
GB8317606D0 (en) Shelters
GB8315519D0 (en) Biologically active mixture
GB8315521D0 (en) Biologically active mixture
PT72614B (en) Active compounds
EG15049A (en) Insecticide composition
PL242930A3 (en) Insecticide